Youngsun Cho, MD/PhD
Assistant Professor
Research & Publications
Biography
News
Research Summary
Dr. Cho's current research focuses on the development of cognitive and motivational brain circuits in adolescents with depression and adolescents with schizophrenia using fMRI, and pharmacologic neuroimaging to identify mechanisms of potential treatments. She is broadly interested in brain development and vulnerability to psychiatric illness. Her work is funded by the NIMH, and the Brain and Behavior Research Foundation. To learn more, please visit her lab website.
Coauthors
Research Interests
Amygdala; Child Development; Cognition; Depression; Motivation; Schizophrenia; Neuroimaging
Selected Publications
- 450. Symptom Severity of Sample Population Impacts the Reproducibility of Neuro-Symptom Relationship in PsychosisLee K, Fonteneau C, Price A, Berkovitch L, Ji J, Tamayo Z, Afriyie-Agyemang Y, Howell A, Repovš G, Murray J, Cho Y, Anticevic A. 450. Symptom Severity of Sample Population Impacts the Reproducibility of Neuro-Symptom Relationship in Psychosis. Biological Psychiatry 2024, 95: s284. DOI: 10.1016/j.biopsych.2024.02.949.
- 249. Interactive Effects of Motivation and Cognition in Adolescents With Depression and Neurotypical PeersPham P, Frazier A, Agrawal S, Anticevic A, Cho Y. 249. Interactive Effects of Motivation and Cognition in Adolescents With Depression and Neurotypical Peers. Biological Psychiatry 2024, 95: s201. DOI: 10.1016/j.biopsych.2024.02.484.
- 215. A Preliminary Interim Analysis of Cognitive Performance in Adolescents With Depression and Neurotypical Peers Using the NIH ToolboxAgrawal S, Pham P, Frazier A, Anticevic A, Cho Y. 215. A Preliminary Interim Analysis of Cognitive Performance in Adolescents With Depression and Neurotypical Peers Using the NIH Toolbox. Biological Psychiatry 2024, 95: s187-s188. DOI: 10.1016/j.biopsych.2024.02.450.
- The Habenula and Our Drive for FoodCho Y. The Habenula and Our Drive for Food. Biological Psychiatry 2024, 95: 912-913. PMID: 38692797, DOI: 10.1016/j.biopsych.2024.03.006.
- Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for PsychosisWannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker J, Bearden C, Billah T, Bouix S, Broome M, Buccilli K, Cadenhead K, Calkins M, Cannon T, Cecci G, Chen E, Cho K, Choi J, Clark S, Coleman M, Conus P, Corcoran C, Cornblatt B, Diaz-Caneja C, Dwyer D, Ebdrup B, Ellman L, Fusar-Poli P, Galindo L, Gaspar P, Gerber C, Glenthøj L, Glynn R, Harms M, Horton L, Kahn R, Kambeitz J, Kambeitz-Ilankovic L, Kane J, Kapur T, Keshavan M, Kim S, Koutsouleris N, Kubicki M, Kwon J, Langbein K, Lewandowski K, Light G, Mamah D, Marcy P, Mathalon D, McGorry P, Mittal V, Nordentoft M, Nunez A, Pasternak O, Pearlson G, Perez J, Perkins D, Powers A, Roalf D, Sabb F, Schiffman J, Shah J, Smesny S, Spark J, Stone W, Strauss G, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum I, Wolf D, Wolff P, Wood S, Yung A, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión R, Castro E, Cetin-Karayumak S, Chakravarty M, Cho Y, Cotter D, D’Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur R, Gur R, Hamilton H, Hoftman G, Jacobs G, Jarcho J, Ji J, Kohler C, Lalousis P, Lavoie S, Lepage M, Liebenthal E, Mervis J, Murty V, Nicholas S, Ning L, Penzel N, Poldrack R, Polosecki P, Pratt D, Rabin R, Eichi H, Rathi Y, Reichenberg A, Reinen J, Rogers J, Ruiz-Yu B, Scott I, Seitz-Holland J, Srihari V, Srivastava A, Thompson A, Turetsky B, Walsh B, Whitford T, Wigman J, Yao B, Yuen H, Ahmed U, Byun A, Chung Y, Do K, Hendricks L, Huynh K, Jeffries C, Lane E, Langholm C, Lin E, Mantua V, Santorelli G, Ruparel K, Zoupou E, Adasme T, Addamo L, Adery L, Ali M, Auther A, Aversa S, Baek S, Bates K, Bathery A, Bayer J, Beedham R, Bilgrami Z, Birch S, Bonoldi I, Borders O, Borgatti R, Brown L, Bruna A, Carrington H, Castillo-Passi R, Chen J, Cheng N, Ching A, Clifford C, Colton B, Contreras P, Corral S, Damiani S, Done M, Estradé A, Etuka B, Formica M, Furlan R, Geljic M, Germano C, Getachew R, Goncalves M, Haidar A, Hartmann J, Jo A, John O, Kerins S, Kerr M, Kesselring I, Kim H, Kim N, Kinney K, Krcmar M, Kotler E, Lafanechere M, Lee C, Llerena J, Markiewicz C, Matnejl P, Maturana A, Mavambu A, Mayol-Troncoso R, McDonnell A, McGowan A, McLaughlin D, McIlhenny R, McQueen B, Mebrahtu Y, Mensi M, Hui C, Suen Y, Wong S, Morrell N, Omar M, Partridge A, Phassouliotis C, Pichiecchio A, Politi P, Porter C, Provenzani U, Prunier N, Raj J, Ray S, Rayner V, Reyes M, Reynolds K, Rush S, Salinas C, Shetty J, Snowball C, Tod S, Turra-Fariña G, Valle D, Veale S, Whitson S, Wickham A, Youn S, Zamorano F, Zavaglia E, Zinberg J, Woods S, Shenton M. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin 2024, 50: 496-512. PMID: 38451304, PMCID: PMC11059785, DOI: 10.1093/schbul/sbae011.
Clinical Trials
Conditions | Study Title |
---|---|
Mental Health & Behavioral Research | Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD |
Diseases of the Nervous System; Mental Health & Behavioral Research | Teen Brain and Behavior Study |
Diseases of the Nervous System; Mental Health & Behavioral Research | Biomarkers of Clinical Subtype and Treatment Response in Obsessive-Compulsive Disorder |